| POS0370 2023 Eular recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases E Dures, B Farisogullari, E Santos, A Molto, C Feldthusen, C Harris, ... Annals of the rheumatic diseases 82 (Suppl 1), 437-438, 2023 | 24 | 2023 |
| Reliability assessment of the definition of ultrasound enthesitis in SpA: results of a large, multicentre, international, web-based study A Di Matteo, E Cipolletta, GM Destro Castaniti, G Smerilli, C Airoldi, ... Rheumatology 61 (12), 4863-4874, 2022 | 19 | 2022 |
| Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experience E Bilgin, F Ceylan, E Duran, B Farisoğullari, EÇ Bölek, GK Yardimci, ... Turkish Journal of Medical Sciences 51 (1), 297-308, 2021 | 19 | 2021 |
| Predictors of remission in people with axial spondyloarthritis: a systematic literature review AS Pinto, B Farisogullari, PM Machado Seminars in Arthritis and Rheumatism 56, 152078, 2022 | 16 | 2022 |
| COVID-19-associated arthritis: an emerging new entity? B Farisogullari, AS Pinto, PM Machado Rmd Open 8 (2), e002026, 2022 | 13 | 2022 |
| Efficacy of non-pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic … EJF Santos, B Farisogullari, E Dures, R Geenen, PM Machado RMD open 9 (3), e003350, 2023 | 12 | 2023 |
| Drug retention rate and predictive factors of drug survival for secukinumab in radiographic axial spondyloarthritis B Armağan, L Kılıç, B Farisoğulları, GK Yardımcı, E Bilgin, EÇ Bölek, ... Rheumatology International 43 (1), 147-156, 2023 | 12 | 2023 |
| EULAR taskforce on recommendations for the management of fatigue in people with inflammatory rheumatic diseases. efficacy of non-pharmacological interventions: a systematic … EJF Santos, B Farisogullari, E Dures RMD Open 9, e003350, 2023 | 7 | 2023 |
| Biologics for immunoglobulin A vasculitis: targeting vasculitis or comorbid disease? B Farisogullari, MK Cuceoglu, H Oral, GK Yardimci, Y Bilginer, S Ozen, ... Internal and emergency medicine 17 (6), 1599-1608, 2022 | 7 | 2022 |
| Real-world data on MTX tolerance with regimens used in children versus adults U Kaya Akca, B Farisogullari, GK Yardimci, E Sag, E Atalay, ... Clinical Rheumatology 40, 5095-5102, 2021 | 6 | 2021 |
| Predictors of drug retention and treatment response in axial spondyloarthritis patients treated with certolizumab: real-life results from the HURBIO registry E Bilgin, B Farisoğulları, B Armağan, A Sarı, GK Yardımcı, EÇ Bölek, ... Clin Exp Rheumatol 6, 2019 | 6 | 2019 |
| Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound … A Di Matteo, G Smerilli, S Di Donato, AR Liu, A Becciolini, F Camarda, ... Annals of the Rheumatic Diseases 83 (7), 847-857, 2024 | 5 | 2024 |
| Pleuroparenchymal fibroelastosis in systemic sclerosis-associated interstitial lung disease A Sari, Ö Önder, B Armağan, EÇ BÖLEK, B Farisoğullari, E Bilgin, ... Turkish Journal of Medical Sciences 52 (1), 83-88, 2022 | 5 | 2022 |
| Efficacy of pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and … B Farisogullari, EJF Santos, E Dures, R Geenen, PM Machado RMD open 9 (4), e003349, 2023 | 4 | 2023 |
| Comprehensive assessment and outcomes of patients with chronic periaortitis G Yardimci, S Duzgun, B Farisogullari, E Bolek, F Eldem, A Erden, L Kiliç, ... Clinical and Experimental Rheumatology 40 (4), 2022 | 4 | 2022 |
| Ab0763 the Influence of obesity on biological DMARD treatment response in psoriatic arthritis: Hur-bio real life results B Farisoğullari, GK Yardimci, EC Bolek, E Bilgin, E Duran, G Ayan, L Kiliç, ... Annals of the Rheumatic Diseases 79 (Suppl 1), 1679-1680, 2020 | 4 | 2020 |
| Correspondence on ‘The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease’by Wallace et al GK Yardımcı, BES Yıldırım, B Farisoğulları, L Kilic, O Karadag Annals of the Rheumatic Diseases 82 (12), e230-e230, 2023 | 3 | 2023 |
| Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported … B Farisogullari, S Lawson-Tovey, KL Hyrich, L Gossec, L Carmona, ... Annals of the rheumatic diseases 83 (11), 1584-1595, 2024 | 2 | 2024 |
| AB0416 CARDIOVASCULAR EVENT, VENOUS THROMBOEMBOLIZM, AND INFECTION RISK WITH TOFACITINIB IN RHEUMATOID ARTHRITIS PATIENTS AGED≥ 60 YEARS E Duran, E Unaldi, E Bilgin, EC Bolek, GK Yardimci, B Farisogullari, ... Annals of the Rheumatic Diseases 81 (Suppl 1), 1336-1336, 2022 | 2 | 2022 |
| Anxiety levels before biologic initiation and changes with treatment in patients with psoriatic arthritis: HUR-BIO biologic registry results G Ayan, B Farisogulları, E Bilgin, EC Bolek, G KübraYardımcı, E Duran, ... Clinical Rheumatology 41 (5), 1439-1446, 2022 | 2 | 2022 |
